Cancer Risk Associated with Use of Metformin and Sulfonylurea in Type 2 Diabetes: A Meta-Analysis
Article 2012 en
Authors
DS
Davide Soranna
LS
Lorenza Scotti
AZ
Antonella Zambon
Abstract
1 min read
Metformin, but not sulfonylurea, appears to reduce subsequent cancer risk. This has relevant implications in light of the exploding global epidemic of diabetes.
Konstantinos K. Tsilidis, Despoina Capothanassi, Naomi E. Allen, Evangelos C. Rizos, David S. López, Karin van Veldhoven, Carlotta Sacerdote, Deborah Ashby, Paolo Vineis, Ioanna Tzoulaki, John P A Ioannidis
Konstantinos K. Tsilidis, Despoina Capothanassi, Naomi E. Allen, Evangelos C. Rizos, David López-Valencia, Karin van Veldhoven, Carlotta Sacerdote, Deborah Ashby, Paolo Vineis, Ioanna Tzoulaki, John P A Ioannidis
Tengteng Wang, Jae H. Kang, Boyang Chai, Wendy Y. Chen, Michelle D. Holmes, Jennifer Erdrich, Edward L. Giovannucci, Frank B Hu, Bernard Rosner, Rulla M. Tamimi, Walter C. Willett, A. Heather Eliassen
Discussion(0)
No comments yet. Be the first to comment.